Tag: Cardiovascular Disease
-
Wegovy Moves Closer to PBS Listing for Adults with Obesity and Heart Disease
What is Wegovy and why the PBS listing matters Semaglutide, marketed as Wegovy, is a prescription medication designed to help adults with obesity lose weight and improve related health risks. The latest development from the Pharmaceutical Benefits Advisory Committee (PBAC) signals a significant step toward adding Wegovy to the Pharmaceutical Benefits Scheme (PBS) for people…
-
Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease
Wegovy Moves Closer to PBS Listing Semaglutide, sold under the brand Wegovy, is nearing a pivotal milestone in Australia’s healthcare system. After preliminary recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), Wegovy could soon be available on the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease who also have obesity. This potential PBS…
-
Wegovy Moves Closer to PBS Listing for Australians with Obesity and Heart Risk
What’s happening with Wegovy and the PBS The anti-obesity drug Wegovy, whose active ingredient is semaglutide, has taken a significant step toward being added to Australia’s Pharmaceutical Benefits Scheme (PBS). The move signals a potential change in how adults living with obesity and established cardiovascular disease could access a proven therapy at a reduced price,…
-
Giving up butter and cheese for heart health? The case against cutting saturated fat
New findings challenge the old wisdom on saturated fat For decades, nutrition guidance has urged people to minimize saturated fats found in butter, cheese, and other animal products to lower heart disease risk. A wave of recent studies, however, is provoking a reevaluation: for many healthy adults, simply cutting butter and cheese may not translate…
-
Concordia researchers identify key marker linking coronary artery disease to cognitive decline
New insight into how heart health shapes brain function Concordia researchers have identified a potential biomarker that links coronary artery disease (CAD) to cognitive decline, offering a possible explanation for why some individuals with heart disease experience faster cognitive aging or dementia. While CAD has long been associated with strokes and vascular-related cognitive impairment, the…
-
AI-Driven CVD Prediction from Longitudinal Iran Data: Development and Validation
Overview Cardiovascular disease (CVD) remains a leading cause of mortality worldwide, with Iran experiencing particularly high rates. This article summarizes a study that develops and validates an artificial intelligence (AI) based model to predict CVD events using longitudinal health data collected over time. By leveraging deep learning and mixed-effects logistic modeling, the research aims to…
-
AI-Based Cardiovascular Disease Prediction: Insights from Longitudinal Data in Iran
Overview Cardiovascular disease (CVD) remains a leading cause of mortality worldwide. In Iran, where mortality rates from heart conditions are notably high, researchers are turning to artificial intelligence (AI) and machine learning (ML) to improve risk prediction. This article summarizes the development and validation of an AI-based model designed to predict cardiovascular events using longitudinal…
-
Social Smoking and Heart Health: Why Even Occasional Smoking Raises Heart Failure Risk
Introduction: A wake-up call about the hidden dangers of social smoking Smoking is often seen as a clear-cut health risk, but a growing body of research suggests that even casual, social smoking can seriously affect heart health. A recent Johns Hopkins study highlights that low-intensity or intermittent smoking is linked to a higher risk of…
-
Even Social Smoking Can Trigger Heart Failure, Johns Hopkins Study Finds
New insights on an old habit When people think of smoking as a major health risk, they often picture heavy, daily use. Yet a growing body of research shows that even light, intermittent, or “social” smoking can significantly impact heart health. A Johns Hopkins study adds to the mounting evidence that no level of smoking…
-
What Ireland’s High-Blood-Pressure Crisis Really Means for Public Health
Introduction: A Quiet but Pressing Health Issue “Some 36% didn’t even know their blood pressure was high. And even in the cases of those who knew and were taking medication to reduce it, 47% weren’t succeeding in bringing their blood pressure down to healthy levels.” This stark statistic underscores a broader crisis in Ireland: high…